Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-05
2005-04-05
Shameem, Golam M M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S315100
Reexamination Certificate
active
06875788
ABSTRACT:
Compounds of formula (I):wherein:R1represents an optionally substituted heteroaryl group,R2represents an optionally substituted cycloalkyl group,R3represents a hydrogen atom or an alkyl group, andR4and R5are as defined in the description, andMedicinal products containing the same are useful in the treatment of non-insulin-dependent type II diabetes, obesity, type I diabetes, hyperlipidaemia, hypercholesterolaemia and cardiovascular complications thereof.
REFERENCES:
patent: 3932431 (1976-01-01), Walter
patent: 4081544 (1978-03-01), Walter
patent: 5389666 (1995-02-01), Hamanaka et al.
patent: 6093727 (2000-07-01), Wong et al.
Bizot-Espiard Jean-Guy
Caignard Daniel-Henri
Kopp Marina
Lancelot Jean-Charles
Lemaitre Stéphane
Les Laboratoires Servier
Shameem Golam M M
The Firm of Hueschen and Sage
LandOfFree
Imidazoline compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazoline compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoline compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3369008